Literature DB >> 1653747

Fibrolamellar carcinoma of the liver--a case report.

T Imai1, H Yokoi, T Noguchi, Y Kawarada, R Mizumoto.   

Abstract

A 36-year-old woman was admitted to our hospital because of general fatigue. The physical and laboratory findings on admission revealed splenomegaly, pancytopenia, hypocoagulopathy, liver hypofunction with a hepaplastin test of 55% and ICG Rmax of 0.6 mg/kg/min. Diagnostic imaging showed a hypoechoic mass 1.5 in diameter a low density area on the CT scan and a faint tumor stain on the AAG in the posterior inferior area of the liver. On a diagnosis of hepatocellular carcinoma with liver cirrhosis and hypersplenism, partial hepatectomy and splenectomy were performed. The resected hepatic specimen revealed a small liver cancer of 1.9 x 1.5 x 1.3 cm with liver cirrhosis. The specimen consisted of a firm rubbery mass. Macroscopically, the tumor appeared oval and was lobulated with a thin capsule. A fibrous scar was observed in the central area. Microscopically, malignant hepatocytes showed various shapes, ranging from polygonal to spindle form, with eosinophilic granular cytoplasm and were surrounded by abundant fibrous stroma. Orcein stain, revealed that these malignant hepatocytes contained many black granules of copper-binding protein. Immunoperoxidase staining for alpha 1-antitrypsin was also positive in the malignant hepatocytes. However, within this lamellar fibrous regions, there were many cords of tumor cells in which nucleoli were absent and abortive biliary differentiation was suggested. Consequently this tumor was diagnosed as an atypical fibrolamellar hepatocellular carcinoma. We think that this case is the 3rd case reported in Japan and the 2nd case in a Japanese person.

Entities:  

Mesh:

Year:  1991        PMID: 1653747     DOI: 10.1007/bf02781929

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  17 in total

1.  Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans.

Authors:  P P Anthony
Journal:  J Pathol       Date:  1973-05       Impact factor: 7.996

2.  Classification of primary malignant tumors of liver in infancy and childhood.

Authors:  K Misugi; H Okajima; N Misugi; W A Newton
Journal:  Cancer       Date:  1967-10       Impact factor: 6.860

3.  Fibrolamellar hepatocarcinoma: radiology, management, and pathology.

Authors:  L K Wong; D P Link; C F Frey; R H Ruebner; H Tesluk; N R Pimstone
Journal:  AJR Am J Roentgenol       Date:  1982-07       Impact factor: 3.959

4.  Fibrolamellar hepatoma.

Authors:  D M Nagorney; M A Adson; L H Weiland; C D Knight; S R Smalley; A R Zinsmeister
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

5.  Fibrolamellar carcinoma of the liver: the malignant counterpart of focal nodular hyperplasia with oncocytic change.

Authors:  F M Vecchio; A Fabiano; G Ghirlanda; R Manna; G Massi
Journal:  Am J Clin Pathol       Date:  1984-04       Impact factor: 2.493

6.  Hyaline cytoplasmic inclusions in human hepatoma. A case report.

Authors:  L Grimelius; U Stenram; J Westman; S Westman-Naeser
Journal:  Acta Cytol       Date:  1977 May-Jun       Impact factor: 2.319

7.  Neurotensin secretion by fibrolamellar carcinoma of the liver.

Authors:  N A Collier; K Weinbren; S R Bloom; Y C Lee; H J Hodgson; L H Blumgart
Journal:  Lancet       Date:  1984-03-10       Impact factor: 79.321

8.  Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.

Authors:  J R Craig; R L Peters; H A Edmondson; M Omata
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

9.  Case report. Hepatocellular carcinoma with lamellar fibrosis: an important histological variant.

Authors:  L J Slavutin; N Diamond
Journal:  Pathology       Date:  1981-10       Impact factor: 5.306

10.  Large hepatocellular cancers: hepatic resection or liver transplantation?

Authors:  O Søreide; A Czerniak; L H Blumgart
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-28
View more
  2 in total

1.  Constitutive activation of nuclear factor-kappa B (NF-kB) signaling pathway in fibrolamellar hepatocellular carcinoma.

Authors:  Wei Li; Dongfeng Tan; Maryam J Zenali; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2009-01-01

Review 2.  Fibrolamellar hepatocellular carcinoma coexistent with a hepatocellular carcinoma of common type: report of a case.

Authors:  K Okada; Y I Kim; K Nakashima; I Tada; T Yoshida; M Kobayashi; S Yokoyama
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.